NTRA:NASDAQ
Natera Inc
390,79 US$
arrow_downward
-1,21%(-4,77) 1K
390,79 US$
0,00% (0,00)
bedtimeYopilgandan keyin
Savdolar yopilgan: 8-okt, 16:00:01 (GMT-4) · USD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoNTRA tikeri uchun statistika yaratilmoqda...
Ochish
387,59 US$
Yuqori
392,96 US$
Past
380,39 US$
Bozor kapitali
56,33 mlrd
Oʻrtacha hajm
1,59 mln
Hajmi
65,00
52 haftalik eng yuqori
437,41 US$
52 haftalik eng past
167,98 US$
Aksiya boʻyicha daromad
-1,37 US$
Beta
1,50
Muomaladagi aksiyalar
144,14 mln
Xodimlar soni
6 ming
Ochish
387,59 US$
Yuqori
392,96 US$
Past
380,39 US$
Bozor kapitali
56,33 mlrd
Oʻrtacha hajm
1,59 mln
Hajmi
65,00
52 haftalik eng yuqori
437,41 US$
52 haftalik eng past
167,98 US$
Aksiya boʻyicha daromad
-1,37 US$
Beta
1,50
Muomaladagi aksiyalar
144,14 mln
Xodimlar soni
6 ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
AD HOC NEWS
·
15 soat oldin
Natera stock falls to EUR 345.95 with P/ E minus 285.7
AD HOC NEWS
·
18 soat oldin
Barclays raises target for Natera stock to USD 475
AD HOC NEWS
·
1 kun oldin
Natera stock trades at USD 396.98 as clinical trials expand
AD HOC NEWS
·
1 kun oldin
Natera launches melanoma trial as Citi lifts Natera stock target to USD 480.00
Profil
Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA testing technology, with a focus on women's health, cancer, and organ health. Natera's proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments in San Carlos, California and Austin, Texas. Wikipedia
Natera Inc haqida
CEOSteven Chapman
Xodimlar soni6,14 ming
Asos solingan1-yan, 2004
Bosh ofislarOstin, Texas, Amerika Qo‘shma Shtatlari
Sektor-
Veb-saytnatera.com